Integrity Capital Management (HK)’s BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock PHGE.U Stock Holding History

Integrity Capital Management (HK)'s PHGE.U Position: Q2 2022 in Review

Integrity Capital Management (HK) sold out of BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock (PHGE.U) in Q2 2022, closing a stake of 180 shares — an estimated $7K sold.

Integrity Capital Management (HK) first reported a position in PHGE.U in Q1 2022 and held it in 1 quarter. The position peaked at $7K in Q1 2022. 1 fund tracked by Wall St. Rank holds PHGE.U as of Q2 2022.

• Integrity Capital Management (HK) reported no remaining BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock position as of Q2 2022 after selling out during the quarter.
• Integrity Capital Management (HK) sold 180 BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock shares in Q2 2022, an estimated $7K.
• Integrity Capital Management (HK) first reported a position in BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock in Q1 2022 and held it in 1 quarter.
• Integrity Capital Management (HK)'s BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock position peaked at $7K in Q1 2022.
• 1 fund tracked by Wall St. Rank held BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock as of Q2 2022.

Based on Integrity Capital Management (HK)'s 13F filing for Q2 2022, filed 28 Jul 2022.